Top Marijuana Stocks: What Investors Should Watch Next
Cannabis stocks are attracting renewed attention as the publicly traded cannabis sector begins to look more financially disciplined. After years of rapid expansion, many leading operators are prioritizing cash flow, stronger balance sheets, efficient retail networks, and measured growth. For investors, this shift may make company fundamentals more important than broad industry hype.
Recent results illustrate the sector’s progress. Trulieve became the first U.S. cannabis company listed on the New York Stock Exchange and reported $53 million in quarterly operating cash flow. Green Thumb Industries also delivered positive net income and maintained a substantial cash position, although pricing pressure remains an industry challenge.
Meanwhile, Curaleaf’s international growth and attempted acquisition of Aurora Cannabis demonstrate how consolidation and global expansion could reshape the cannabis industry. Nevertheless, marijuana stocks remain volatile. Regulatory uncertainty, heavy taxation, limited access to conventional banking, price compression, and substantial debt can quickly affect valuations. Federal reform may provide a catalyst, but investors should avoid building an entire thesis around political timelines.
The long-term opportunity remains compelling as legal markets expand and stronger businesses gain market share. However, success in pot stocks will likely depend on careful selection. Investors evaluating top marijuana stocks should emphasize sustainable margins, operating cash flow, manageable debt, brand strength, and exposure to attractive state or international markets. Below are several marijuana stocks to watch in today’s market.
Top Marijuana Stocks For Investors 2026
- Jushi Holdings Inc. (OTC:JUSHF)
- Curaleaf Holdings, Inc. (OTC:CURLF)
- Verano Holdings Corp. (OTC:VRNOF)
Jushi Holdings Inc.
Among smaller cannabis stocks, Jushi Holdings is a vertically integrated multistate operator involved in cultivation, manufacturing, wholesale distribution, and retail. Its dispensaries primarily operate under the Beyond Hello brand, while its product portfolio includes flower, concentrates, vapes, pre-rolls and edibles. At the end of the second quarter, Jushi operated 42 dispensaries across eight states.
Jushi reported encouraging growth in Q2 2026. Revenue increased 10% year over year to $71.3 million, led by retail growth in Ohio and Virginia. Wholesale revenue climbed 68% to a quarterly record of $9.4 million, while adjusted EBITDA reached $13.3 million. Its net loss improved from $12.3 million to $7.3 million. 
Virginia represents an important future catalyst: Jushi already operates six dispensaries there, and regulated adult-use sales are scheduled to begin July 1, 2027. The primary investor concern is its balance sheet. Jushi held $35.5 million in cash against about $219.8 million in debt with scheduled repayments, while quarterly operating cash flow was only $0.8 million. For investors, JUSHF offers meaningful growth potential, but financing costs, dilution risk, and execution in Virginia deserve close attention.
Curaleaf Holdings, Inc.
Curaleaf Holdings is a major international cannabis company with cultivation, manufacturing, wholesale and retail operations across the United States and Europe. Its portfolio includes Curaleaf, Select, Grassroots, Find and JAMS, giving the business exposure to flower, vapes, edibles, concentrates and medical cannabis. CURLF trades on the OTCQX market, while its Canadian-listed shares trade as CURA.
Curaleaf reported Q2 2026 revenue of $340.1 million, increasing 10% year over year. Gross margin improved to 50%, and the company reported $12.5 million in income from continuing operations, up from a $48.1 million loss a year earlier. 
International revenue grew 26% to $51.4 million, supported by expanding medical-cannabis sales in Germany and the United Kingdom. The company’s most notable recent development is its unsolicited approximately $272 million takeover offer for Aurora Cannabis. Aurora’s board rejected the proposal as inadequate, creating uncertainty around the transaction and its potential financing, dilution, and integration demands. For investors, Curaleaf offers broad geographic reach and growing international exposure. However, debt, acquisition risk, federal restrictions and competitive pricing remain important concerns. CURLF may benefit from industry consolidation, but investors should watch profitability, leverage, and the outcome of the Aurora bid.
[Read More] Cannabis Stocks Enter A New Era For Investors nd Enthusiasts
Verano Holdings Corp.
Cannabis stocks such as Verano Holdings Corp. offer investors exposure to a large, vertically integrated operator in the U.S. cannabis industry. Headquartered in Chicago, Verano cultivates and processes cannabis, manufactures branded products, and serves medical patients and recreational consumers through its Zen Leaf and MÜV dispensaries. Its brand portfolio includes Savvy, Encore, BITS, Avexia, Essence, HYPHEN, and Verano. 
As of August 2026, the company operated across 13 states with 163 dispensaries, 14 production facilities, and more than 1.1 million square feet of cultivation capacity. Verano’s second-quarter revenue increased 8% year over year to $218 million, marking its third consecutive quarter of revenue growth. The company also produced $31 million in operating cash flow and $51 million in adjusted EBITDA, although it recorded a $13 million net loss.
[Read More] 3 Cannabis Stocks to Watch Heading Out of September
For investors, Verano’s expanding revenue, recognizable brands, and positive operating cash flow are encouraging. However, its $393 million in debt, declining gross margin, continuing net losses, pricing pressure, and federal regulatory uncertainty remain important risks. Future performance will depend on controlling expenses, strengthening margins, reducing debt, and converting its substantial operating footprint into consistent profitability.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
